This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Jefferies Keeps Their Buy Rating on Thermo Fisher (TMO)
Jefferies analyst maintained a Buy rating on Thermo Fisher today and set a price target of $585.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
In addition to Jefferies, Thermo Fisher also received a Buy from Stifel Nicolaus’s Daniel Arias in a report issued today. However, on May 14, RBC Capital initiated coverage with a Hold rating on Thermo Fisher (NYSE: TMO).
Based on Thermo Fisher’s latest earnings release for the quarter ending March 28, the company reported a quarterly revenue of $11.01 billion and a net profit of $1.65 billion. In comparison, last year the company earned a revenue of $10.36 billion and had a net profit of $1.51 billion
Read More on TMO:
Disclaimer & DisclosureReport an Issue
- Thermo Fisher Scientific: Buy Rating Reaffirmed on Strengthening Organic Growth Outlook, Market Share Gains, and AI-Driven Demand Tailwinds
- Thermo Fisher highlights growth outlook, long-term value creation
- Thermo Fisher sees low-teens adjusted EPS growth over the long-term
- Amazon among seven added to Jefferies’ Franchise Picks list
- Thermo Fisher resumed with a Sector Perform at RBC Capital
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
